FDA
-
-
-
-
-
-
-
CervoMed nfvPPA trial data to be presented at ISFTD meeting
-
-
-
-
-
-
-
CervoMed presents neflamapimod DLB trial data at AAIC 2026
-
-
-
-
-
-
-
CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
-
-
-
-
-
-
-
CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
-
-
-
-
-
-
-
CervoMed shares new data showing drug benefits for dementia patients
-
-
-
-
-
-
-
CervoMed’s neflamapimod elected for inclusion in UK EXPERTS-ALS platform designed to prioritize promising treatments for Amyotrophic Lateral Sclerosis
-
-
-
-
-
-
-
CervoMed gains FDA alignment for dementia with Lewy bodies drug trial
-
335,228 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


